Carnegie Capital Asset Management LLC Has $390,000 Position in MetLife, Inc. (NYSE:MET)

Carnegie Capital Asset Management LLC raised its stake in MetLife, Inc. (NYSE:MET) by 4.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 5,905 shares of the financial services provider’s stock after buying an additional 253 shares during the period. Carnegie Capital Asset Management LLC’s holdings in MetLife were worth $390,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. IHT Wealth Management LLC grew its stake in shares of MetLife by 4.5% in the fourth quarter. IHT Wealth Management LLC now owns 3,466 shares of the financial services provider’s stock valued at $251,000 after acquiring an additional 150 shares in the last quarter. Carolinas Wealth Consulting LLC grew its stake in shares of MetLife by 26.4% in the first quarter. Carolinas Wealth Consulting LLC now owns 767 shares of the financial services provider’s stock valued at $54,000 after acquiring an additional 160 shares in the last quarter. Harbour Investments Inc. grew its stake in shares of MetLife by 3.2% in the fourth quarter. Harbour Investments Inc. now owns 5,269 shares of the financial services provider’s stock valued at $381,000 after acquiring an additional 162 shares in the last quarter. Eley Financial Management Inc lifted its position in MetLife by 1.0% during the third quarter. Eley Financial Management Inc now owns 16,348 shares of the financial services provider’s stock worth $1,028,000 after purchasing an additional 168 shares during the period. Finally, Austin Private Wealth LLC lifted its position in MetLife by 4.1% during the fourth quarter. Austin Private Wealth LLC now owns 4,367 shares of the financial services provider’s stock worth $289,000 after purchasing an additional 170 shares during the period. 89.81% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on MET shares. Wells Fargo & Company upped their price objective on shares of MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Piper Sandler upped their price objective on shares of MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. UBS Group cut their price objective on shares of MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research report on Monday, February 5th. Keefe, Bruyette & Woods increased their target price on shares of MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a report on Wednesday, April 10th. Finally, The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and increased their target price for the stock from $70.00 to $80.00 in a report on Monday, January 8th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.23.

Insider Buying and Selling at MetLife

In other MetLife news, EVP Bill Pappas sold 27,000 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other MetLife news, EVP Bill Pappas sold 27,000 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

MetLife Stock Performance

MetLife stock opened at $68.92 on Thursday. The business has a 50 day moving average of $70.98 and a 200-day moving average of $66.68. MetLife, Inc. has a 1 year low of $48.95 and a 1 year high of $74.68. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market capitalization of $49.83 billion, a P/E ratio of 37.66, a P/E/G ratio of 0.52 and a beta of 1.04.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). The firm had revenue of $18.72 billion during the quarter, compared to analyst estimates of $18.07 billion. MetLife had a net margin of 2.36% and a return on equity of 19.48%. On average, equities research analysts predict that MetLife, Inc. will post 8.71 earnings per share for the current year.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.